Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Hepatology. 2012 Nov;56(5):1782–1791. doi: 10.1002/hep.25868

Fig. 3. Alb/AEG-1 hepatocytes demonstrate chemoresistance and resistance to growth factor deprivation.

Fig. 3

WT and Alb/AEG-1 hepatocytes were treated either with Doxorubicin (DOX; 5 nM) (A) or with 5-fluorouracil (5-FU; 100 nM) (B) and cell viability was analyzed by standard MTT assay. C. WT and Alb/AEG-1 hepatocytes were cultured either in complete media or in basal media devoid of growth factors and cell viability was analyzed by standard MTT assay. For A-C, cell viability at day 0 (D0) was considered as 100%. The data represent mean ± SEM of three independent experiments. # and *: p<0.01 comparing WT and Alb/AEG-1 of the same treatment groups. D. The expression of the indicated proteins was analyzed by Western blot using lysates from WT and Alb/AEG-1 hepatocytes.